April 2020 marks the second anniversary of the new pre-revenue biotech listing regime under Chapter 18A of the Listing Rules that has helped a total of 16 companies to list on the HKEx so...
Recognizing that many companies will have “urgent liquidity needs” in the coming months as a result economic and market conditions related to the spread of COVID-19, on Monday the New...
The SEC issued an order on Wednesday that provides companies that are unable to comply with their filing obligations as a result of coronavirus (COVID-19) with additional time to file rep...
The SEC has historically imposed burdensome financial statement requirements on companies that issue debt that is either guaranteed by subsidiaries or secured. Because most high yield deb...
Last week, the Securities and Exchange Commission proposed broad changes to the current private offering framework. Recognizing the growing market for private investments, this is the lat...
On January 30, the Securities and Exchange Commission released interpretive guidance for companies regarding disclosure of key performance indicators and other metrics in Management’s D...
Last week the SEC issued three new Compliance & Disclosure Interpretations intended to give clarity to last spring’s rule changes that allowed companies to omit discussion of the earlie...
Proposed amendments to definitions of “accredited investor” and “qualified institutional buyer” would expand private-offering access for individuals and entities beyond current te...
On December 18, the SEC proposed rules that would require resource extraction companies to disclose payments made to foreign governments or to the U.S. federal government for the commerci...
The SEC staff recently provided guidance for companies on disclosing risks to their intellectual property, technology and data arising from international operations, particularly in juris...
